Home » Research » Shared Core Facilities » Vaccine and Cell Therapy

Publications

  • O'Neill DW, Adams S and Bhardwaj N. (2004). Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood, 104,2235-2246.

  • O'Neill D and Bhardwaj N. (2005). Exploiting dendritic cells for active immunotherapy of cancer and chronic infections. In: Ludewig B, Hoffmann MW, eds. Adoptive Immunotherapy — Methods and Protocols. pp 1-18. Methods in Molecular Medicine. Humana Press, Totowa, NJ.

  • O'Neill D and Bhardwaj N. (2005). Generation of autologous peptide- and protein-pulsed dendritic cells for patient-specific immunotherapy. In: Ludewig B, Hoffmann MW, eds. Adoptive Immunotherapy — Methods and Protocols. pp. 97-112. Methods in Molecular Medicine. Humana Press, Totowa, NJ.

  • O'Neill DW and Bhardwaj N. (2005). Differentiation of peripheral blood monocytes into dendritic cells. In: Bierer, B.E., Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, eds. Current Protocols in Immunology. pp. 22F.4.1-22F.4.9. John Wiley & Sons, Hoboken, NJ.

  • Adams S, O'Neill DW and Bhardwaj N. (2005). Recent advances in dendritic cell biology. J Clin Immunol, 25, 87-98.

  • Skoberne M, Beignon AS, Larsson M, Bhardwaj N. (2005) Apoptotic cells at the crossroads of tolerance and immunity. Curr Top Microbiol Immunol, 289, 259-92.

  • Kavanagh DG, Kaufmann DE, Sunderji S, Frahm N, Le Gall S, Boczkowski D, Rosenberg ES, Stone DR, Johnston MN, Wagner BS, Zaman MT, Brander C, Gilboa E, Walker BD and Bhardwaj N. (2006) Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef. Blood, 107, 1963-1969. 

  • Valmori, D., Souleimanian, N.E., Tosello, V., Bhardwaj, N., Adams, A., O'Neill, D., Pavlick, A., Escalon, J.B., Cruz, C.M., Angiulli, A., Angiulli, F., Mears, G., Vogel, S.M., Pan, L., Jungbluth, A.A., Hoffmann, E.W., Venhaus, R., Ritter, G., Old, L.J. and Ayyoub, M.. (2007). Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming. Proc. Natl. Acad. Sci. USA., 104, 8947-8952.

  • O'Neill D.W. and Bhardwaj, N. (2007). Armed and ready: How effector T cells deploy in reactive lymph nodes to modulate immunity. Nature Immunol., 8, 679-681.

  • O'Neill, D.W. and Bhardwaj, N. (2007). Exploiting dendritic cells for active immunotherapy of cancer and chronic infections. Mol. Biotechnol., 36, 131-141.

  • Bhardwaj, N. (2007). Harnessing the immune system to treat cancer. J. Clin. Invest., 117, 1130-1136.

  • Adams, S., O'Neill, D.W., Nonaka, D., Hardin, E., Chiriboga, L., Siu, K., Cruz, C.M., Angiulli, A., Angiulli, F., Ritter, E., Holman, R.M., Shapiro, R.L., Berman, R.S., Berner, N., Shao, Y., Manches, O., Pan, L., Venhaus, R.R., Hoffman, E.W., Jungbluth, A., Gnjatic, S., Old, L., Pavlick, A., Bhardwaj, N. Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using Toll-like receptor 7 agonist imiquimod as vaccine adjuvant. Submitted for publication.